These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27566738)

  • 1. Miracle drug: Brazil approves never-tested cancer medicine.
    Kuchenbecker RS; Mota DM
    J Oncol Pharm Pract; 2017 Jul; 23(5):399-400. PubMed ID: 27566738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Governance and pharmacovigilance in Brazil: a scoping review.
    Moscou K; Kohler JC; MaGahan A
    J Pharm Policy Pract; 2016; 9():3. PubMed ID: 26862438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions?
    Lipska I; Hoekman J; McAuslane N; Leufkens HG; Hövels AM
    Clin Pharmacol Ther; 2015 Nov; 98(5):489-91. PubMed ID: 26250656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CANCER RESEARCH. Brazil bill would legalize renegade cancer pill.
    Escobar H
    Science; 2016 Apr; 352(6281):18. PubMed ID: 27034350
    [No Abstract]   [Full Text] [Related]  

  • 5. Law 13,269/2016: clamor by society trumps the scientific method!
    Alves SM; Delduque MC; Santos AO
    Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27338819
    [No Abstract]   [Full Text] [Related]  

  • 6. ['Judicialization' of public health policy for distribution of medicines].
    Chieffi AL; Barata RB
    Cad Saude Publica; 2009 Aug; 25(8):1839-49. PubMed ID: 19649425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends and challenges in the European regulation of innovative medicines.
    Enzmann H
    Regul Toxicol Pharmacol; 2016 Oct; 80():314-20. PubMed ID: 27237379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.
    Elias FT; Araújo DV
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):405-12. PubMed ID: 25444299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Federal procurement of unlicensed medicines in Brazil; findings and implications.
    Teodoro CRDS; Caetano R; Godman B; Dos Reis ALA; Maia AA; Ramos MCB; Osorio-de-Castro CGS
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):607-613. PubMed ID: 28330384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fertility transition in Brazil. Causes and consequences].
    Carvalho JA; Wong LR
    Notas Poblacion; 1992 Dec; 20(56):107-41. PubMed ID: 12287031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching safety to access: global actors and pharmacogovernance in Kenya- a case study.
    Moscou K; Kohler JC
    Global Health; 2017 Mar; 13(1):20. PubMed ID: 28335786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation and adoption of health technologies under Brazil's Unified Health System: barriers to access to medicines for diseases of poverty?
    Santana RS; Lupatini EO; Leite SN
    Cien Saude Colet; 2017 May; 22(5):1417-1428. PubMed ID: 28538914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Governance in Brazil's Unified Health System: a conceptual essay.
    Ribeiro PT; Tanaka OY; Denis JL
    Cien Saude Colet; 2017 Apr; 22(4):1075-1084. PubMed ID: 28444035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health promotion and health education at the school of governance in health, National School of Public Health, Brazil].
    Buss PM
    Cad Saude Publica; 1999 Nov; 15 Suppl 2():177-85. PubMed ID: 10578089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Civil society participation in the health system: the case of Brazil's Health Councils.
    Martinez MG; Kohler JC
    Global Health; 2016 Oct; 12(1):64. PubMed ID: 27782831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family planning and population policy in Brazil.
    Sanders TG
    UFSI Rep; 1984 Aug; (16):1-7. PubMed ID: 12313401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamine.
    Rêgo JF; Lopes G; Riechelmann RP; Sternberg C; Ferrari C; Fernandes G
    Rev Assoc Med Bras (1992); 2017 Jan; 63(1):70-77. PubMed ID: 28225882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer: Is it really so different? Particularities of oncologic drugs from the perspective of the pharmaceutical regulatory agency].
    Enzmann H; Broich K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(2):120-8. PubMed ID: 23663906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of HIV/AIDS response in Brazil: Policy innovations and challenges in the fourth decade of the epidemic.
    da Fonseca EM; Bastos FI
    Int J Health Plann Manage; 2018 Jan; 33(1):e238-e250. PubMed ID: 28875508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.